Literature DB >> 27924821

Critical role of TSLP-responsive mucosal dendritic cells in the induction of nasal antigen-specific IgA response.

S Joo1,2, Y Fukuyama1, E J Park1,3, Y Yuki1, Y Kurashima1,2, R Ouchida1, S F Ziegler4, H Kiyono1,2,5,6.   

Abstract

Thymic stromal lymphopoietin (TSLP) is an interleukin-7 (IL-7)-like cytokine involved in T helper 2 type immune responses. The primary target of TSLP is myeloid dendritic cells (DCs), however, little is known about the mechanism by which TSLP elicits respiratory IgA immune responses upon mucosal immunization. Here, we found that the levels of TSLP and TSLPR were upregulated in the mucosal DCs of mice nasally immunized with pneumococcal surface protein A (PspA) plus cholera toxin (CT) compared with those immunized with PspA alone. PspA-specific IgA responses, but not IgG Ab responses were significantly reduced in both serum and mucosal secretions of TSLPR knockout mice compared with wild-type mice after nasal immunization with PspA plus CT. Furthermore, CD11c+ mucosal DCs isolated from TSLPR knockout mice nasally immunized with PspA plus CT were less activated and exhibited markedly reduced expression of IgA-enhancing cytokines (e.g., APRIL, BAFF, and IL-6) compared with those from equivalently immunized wild-type mice. Finally, exogenous TSLP promoted production of IgAs in an in vitro DC-B cell co-culture system as exhibited by enhanced IL-6 production. These results suggest that TSLP-TSLPR signaling is pivotal in the induction of nasal respiratory immunity against pathogenic pneumococcal infection.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27924821     DOI: 10.1038/mi.2016.103

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  44 in total

1.  Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae.

Authors:  D E Briles; E Ades; J C Paton; J S Sampson; G M Carlone; R C Huebner; A Virolainen; E Swiatlo; S K Hollingshead
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

2.  CpG motifs as immune adjuvants.

Authors:  D M Klinman; K M Barnhart; J Conover
Journal:  Vaccine       Date:  1999-01       Impact factor: 3.641

Review 3.  Novel vaccine development strategies for inducing mucosal immunity.

Authors:  Yoshiko Fujkuyama; Daisuke Tokuhara; Kosuke Kataoka; Rebekah S Gilbert; Jerry R McGhee; Yoshikazu Yuki; Hiroshi Kiyono; Kohtaro Fujihashi
Journal:  Expert Rev Vaccines       Date:  2012-03       Impact factor: 5.217

4.  Human thymic stromal lymphopoietin preferentially stimulates myeloid cells.

Authors:  P A Reche; V Soumelis; D M Gorman; T Clifford; M Travis; S M Zurawski; J Johnston; Y J Liu; H Spits; R de Waal Malefyt; R A Kastelein; J F Bazan
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

5.  Pneumococcal surface protein A (PspA) is serologically highly variable and is expressed by all clinically important capsular serotypes of Streptococcus pneumoniae.

Authors:  M J Crain; W D Waltman; J S Turner; J Yother; D F Talkington; L S McDaniel; B M Gray; D E Briles
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

6.  Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae.

Authors:  H Y Wu; M H Nahm; Y Guo; M W Russell; D E Briles
Journal:  J Infect Dis       Date:  1997-04       Impact factor: 5.226

7.  TSLP-activated dendritic cells induce an inflammatory T helper type 2 cell response through OX40 ligand.

Authors:  Tomoki Ito; Yui-Hsi Wang; Omar Duramad; Toshiyuki Hori; Guy J Delespesse; Norihiko Watanabe; F Xiao-Feng Qin; Zhengbin Yao; Wei Cao; Yong-Jun Liu
Journal:  J Exp Med       Date:  2005-11-07       Impact factor: 14.307

8.  A role for TSLP in the development of inflammation in an asthma model.

Authors:  Amin Al-Shami; Rosanne Spolski; John Kelly; Andrea Keane-Myers; Warren J Leonard
Journal:  J Exp Med       Date:  2005-09-19       Impact factor: 14.307

9.  The transcription factor STAT5 is critical in dendritic cells for the development of TH2 but not TH1 responses.

Authors:  Bryan D Bell; Masayuki Kitajima; Ryan P Larson; Thomas A Stoklasek; Kristen Dang; Kazuhito Sakamoto; Kay-Uwe Wagner; Daniel H Kaplan; Boris Reizis; Lothar Hennighausen; Steven F Ziegler
Journal:  Nat Immunol       Date:  2013-02-24       Impact factor: 25.606

10.  Potential roles of CCR5(+) CCR6(+) dendritic cells induced by nasal ovalbumin plus Flt3 ligand expressing adenovirus for mucosal IgA responses.

Authors:  Yoshiko Fukuyama; Daisuke Tokuhara; Shinichi Sekine; Kazuyoshi Aso; Kosuke Kataoka; Julia Davydova; Masato Yamamoto; Rebekah S Gilbert; Yuka Tokuhara; Keiko Fujihashi; Jun Kunisawa; Yoshikazu Yuki; Hiroshi Kiyono; Jerry R McGhee; Kohtaro Fujihashi
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more
  11 in total

Review 1.  Immunity to gastrointestinal nematode infections.

Authors:  D Sorobetea; M Svensson-Frej; R Grencis
Journal:  Mucosal Immunol       Date:  2018-01-03       Impact factor: 7.313

Review 2.  The Role of BAFF System Molecules in Host Response to Pathogens.

Authors:  Jiro Sakai; Mustafa Akkoyunlu
Journal:  Clin Microbiol Rev       Date:  2017-10       Impact factor: 26.132

3.  Preclinical Efficacy of a Trivalent Human FcγRI-Targeted Adjuvant-Free Subunit Mucosal Vaccine against Pulmonary Pneumococcal Infection.

Authors:  Sudeep Kumar; Raju Sunagar; Edmund J Gosselin
Journal:  Vaccines (Basel)       Date:  2020-04-23

4.  Mesenteric CD103+DCs Initiate Switched Coxsackievirus B3 VP1-Specific IgA Response to Intranasal Chitosan-DNA Vaccine Through Secreting BAFF/IL-6 and Promoting Th17/Tfh Differentiation.

Authors:  Haoxin Zhao; Jie Yang; Qian Qian; Manli Wu; Min Li; Wei Xu
Journal:  Front Immunol       Date:  2018-12-18       Impact factor: 7.561

5.  Toll-Like Receptor 2 (TLR2) and TLR4 Mediate the IgA Immune Response Induced by Mycoplasma hyopneumoniae.

Authors:  Xia Li; Yun-Ke Zhang; Bao Yin; Jing-Bo Liang; Fei Jiang; Wen-Xue Wu
Journal:  Infect Immun       Date:  2019-12-17       Impact factor: 3.441

6.  Interferon-λ Improves the Efficacy of Intranasally or Rectally Administered Influenza Subunit Vaccines by a Thymic Stromal Lymphopoietin-Dependent Mechanism.

Authors:  Liang Ye; Daniel Schnepf; Annette Ohnemus; Li Ching Ong; Hans Henrik Gad; Rune Hartmann; Nils Lycke; Peter Staeheli
Journal:  Front Immunol       Date:  2021-09-29       Impact factor: 7.561

Review 7.  The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection.

Authors:  Oreste Gallo; Luca Giovanni Locatello; Alessio Mazzoni; Luca Novelli; Francesco Annunziato
Journal:  Mucosal Immunol       Date:  2020-11-26       Impact factor: 7.313

8.  The Protective HIV-1 Envelope gp41 Antigen P1 Acts as a Mucosal Adjuvant Stimulating the Innate Immunity.

Authors:  Lin Xu; Daniela Tudor; Morgane Bomsel
Journal:  Front Immunol       Date:  2021-02-03       Impact factor: 7.561

9.  Asthma-Associated Long TSLP Inhibits the Production of IgA.

Authors:  Dorianne van Heerden; Robert S van Binnendijk; Samantha A M Tromp; Huub F J Savelkoul; R J Joost van Neerven; Gerco den Hartog
Journal:  Int J Mol Sci       Date:  2021-03-30       Impact factor: 5.923

Review 10.  Epithelial Barrier Dysfunction in Chronic Respiratory Diseases.

Authors:  François M Carlier; Charlotte de Fays; Charles Pilette
Journal:  Front Physiol       Date:  2021-06-24       Impact factor: 4.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.